Diana Zuckerman is president of the National Center for Health Research, a nonprofit think tank based in Washington, D.C.
Diana Zuckerman
President
National Center for Health Research
From this contributor
How the new U.S. ‘Right to Try’ law could harm people with autism
People with autism already have access to experimental treatments; the new law could make that access more dangerous.
How the new U.S. ‘Right to Try’ law could harm people with autism
By
Diana Zuckerman
3 July 2018 | 5 min read
Why the 21st Century Cures Act could be disastrous for medicine
A new bill threatens to lower the scientific standards that have made the Food and Drug Administration's approval the gold standard worldwide.
Why the 21st Century Cures Act could be disastrous for medicine
By
Diana Zuckerman
1 December 2016 | 6 min read
Explore more from The Transmitter
Prevalence of profound autism declines with new definition
The updated, more precise definition used in a CDC study includes adaptive scores.
Prevalence of profound autism declines with new definition
The updated, more precise definition used in a CDC study includes adaptive scores.
By
Brianna Abbott
22 October 2026 | 5 min read
Is it time for neuroscience to shift its focus from a computational mind to a navigating mind?
Andrea Hiott explains her navigational approach to the mind, and why now is the time to embrace seemingly paradoxical findings in neuroscience.
Is it time for neuroscience to shift its focus from a computational mind to a navigating mind?
Andrea Hiott explains her navigational approach to the mind, and why now is the time to embrace seemingly paradoxical findings in neuroscience.
By
Paul Middlebrooks
21 October 2026 | 1 min read
Human brain organoids come of age—but still have room to grow
The U.S. government has touted organoids as an alternative to animals for studying the brain. The model has improved since its debut in 2013, but scientists are still working to overcome key limitations: immaturity, consistency and the lack of vascularization.
Human brain organoids come of age—but still have room to grow
The U.S. government has touted organoids as an alternative to animals for studying the brain. The model has improved since its debut in 2013, but scientists are still working to overcome key limitations: immaturity, consistency and the lack of vascularization.
By
Claudia López Lloreda
21 October 2026 | 9 min read